lobbying_activities: 1108723

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1108723	423624a8-f9f1-4bfe-90f4-2b03140f9aae	Q2	PARRY, ROMANI, DECONCINI & SYMMS	30792	BRAIDWOOD MANAGEMENT, INC.	2011	second_quarter	PHA	Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practioner acting in the usual course of professional practice. No specific legislation yet.	HOUSE OF REPRESENTATIVES,SENATE	11250		0	0	2011-07-08T14:58:18.923000-04:00